Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Ana Mercedes García-Albisua, ASCRS 2022: Bowman Layer Transplantation Using a Femtosecond Laser: 3 Years Results

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 19th 2022

The aims, design and findings of the retrospective study evaluating the 3-year clinical outcomes of isolated Bowman layer transplantation using femtosecond laser as a treatment for patients with progressive keratoconus is discussed in this touchOPHTHALMOLOGY interview with Dr Ana Mercedes García-Albisua (Hospital “Luis Sánchez Bulnes”, México City, México) as well as how possible complications of this procedure may be minimised.

The presentation entitled ‘Bowman Layer Transplantation Using a Femtosecond Laser: 3 Years Results’ was presented at the American Society of Cataract and Refractive Surgery, April 22-26, 2022

Questions:

  1. Could you tell us a little about your retrospective study and its findings?
  2. Which patients are the ideal candidates for this treatment and in whom is it contraindicated?
  3. What is known about possible complications of this procedure and how may these be minimised?

Disclosures: Ana Mercedes García-Albisua has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.

Filmed in coverage of the virtual ASCRS 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup